Awor S, Bongomin F, Kaggwa M, Pebolo F, Epila J, Malinga G
Syst Rev. 2024; 13(1):260.
PMID: 39407336
PMC: 11479572.
DOI: 10.1186/s13643-024-02662-6.
Monagel D, Algahtani S, Karawagh L, Althubaity W, Azab S, Haneef D
Front Pediatr. 2024; 11:1295883.
PMID: 38161437
PMC: 10755027.
DOI: 10.3389/fped.2023.1295883.
Meesters K, Alemayehu T, Benou S, Buonsenso D, Decloedt E, Pillay-Fuentes Lorente V
Antibiotics (Basel). 2023; 12(1).
PMID: 36671218
PMC: 9854442.
DOI: 10.3390/antibiotics12010017.
Adebayo O, Nkoy A, Van den Heuvel L, Labarque V, Levtchenko E, Delanaye P
Pediatr Nephrol. 2022; 38(8):2529-2547.
PMID: 36472656
DOI: 10.1007/s00467-022-05826-5.
Pottel H, Adebayo O, Nkoy A, Delanaye P
Pediatr Nephrol. 2022; 38(8):2523-2527.
PMID: 36459244
DOI: 10.1007/s00467-022-05827-4.
Glomerular Biomechanical Stress and Lipid Mediators during Cellular Changes Leading to Chronic Kidney Disease.
Sharma M, Singh V, Sharma R, Koul A, McCarthy E, Savin V
Biomedicines. 2022; 10(2).
PMID: 35203616
PMC: 8962328.
DOI: 10.3390/biomedicines10020407.
Hemodynamic and biological correlates of glomerular hyperfiltration in sickle cell patients before and under renin-angiotensin system blocker.
Haymann J, Hammoudi N, Livrozet M, Santin A, Mattioni S, Letavernier E
Sci Rep. 2021; 11(1):11682.
PMID: 34083624
PMC: 8175337.
DOI: 10.1038/s41598-021-91161-y.
Kidney Function Decline among Black Patients with Sickle Cell Trait and Sickle Cell Disease: An Observational Cohort Study.
Olaniran K, Allegretti A, Zhao S, Achebe M, Eneanya N, Thadhani R
J Am Soc Nephrol. 2019; 31(2):393-404.
PMID: 31810990
PMC: 7003305.
DOI: 10.1681/ASN.2019050502.
Prevalence and factors associated with renal dysfunction among children with sickle cell disease attending the sickle cell disease clinic at a tertiary hospital in Northwestern Tanzania.
Kimaro F, Jumanne S, Sindato E, Kayange N, Chami N
PLoS One. 2019; 14(6):e0218024.
PMID: 31211789
PMC: 6581240.
DOI: 10.1371/journal.pone.0218024.
Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice.
Kasztan M, Fox B, Lebensburger J, Hyndman K, Speed J, Pollock J
Blood Adv. 2019; 3(9):1460-1475.
PMID: 31064747
PMC: 6517665.
DOI: 10.1182/bloodadvances.2018028878.
VEGF Promoter Region 18-bp Insertion-Deletion Polymorphism in Sickle Cell Disease Patients with Microalbuminuria: A Pilot Study.
Amle D, Patnayak R, Verma V, Singh G, Jain V, Khodiar P
Indian J Hematol Blood Transfus. 2019; 35(2):278-283.
PMID: 30988564
PMC: 6439237.
DOI: 10.1007/s12288-018-1018-x.
Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment.
Hariri E, Mansour A, El Alam A, Daaboul Y, Korjian S, Bahous S
Int Urol Nephrol. 2018; 50(6):1075-1083.
PMID: 29383580
DOI: 10.1007/s11255-018-1803-3.
Dose Selection Based on Modeling and Simulation for Rivipansel in Pediatric Patients Aged 6 to 11 Years With Sickle Cell Disease.
Tammara B, Harnisch L
CPT Pharmacometrics Syst Pharmacol. 2017; 6(12):845-854.
PMID: 29115052
PMC: 5744176.
DOI: 10.1002/psp4.12263.
Glomerular filtration rate is altered in children with sickle cell disease: a comparison between Hb SS and Hb SC.
Paula R, Nascimento A, Bispo Sousa S, Bastos P, Barbosa A
Rev Bras Hematol Hemoter. 2013; 35(5):349-51.
PMID: 24255619
PMC: 3832316.
DOI: 10.5581/1516-8484.20130107.
Vasculature and kidney complications in sickle cell disease.
Nath K, Katusic Z
J Am Soc Nephrol. 2012; 23(5):781-4.
PMID: 22440903
PMC: 3338300.
DOI: 10.1681/ASN.2011101019.
